Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for orbitofrontal–ventral striatal connectivity in obsessive-compulsive disorder
jRCTs051180040Active, not recruiting
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of acetylcysteine in obsessive compulsive disorder (OCD) (2 arms). Primary endpoint: Functional and structural connectivity between orbitofrontal cortex and ventral striatum. Started Sep 2019; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on jRCTs051180040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180040.